(0.36%) 5 110.00 points
(0.75%) 38 668 points
(0.62%) 17 760 points
(0.68%) $79.49
(1.03%) $2.06
(-0.10%) $2 307.30
(-0.48%) $26.70
(0.79%) $970.20
(-0.20%) $0.930
(-0.84%) $10.90
(-0.18%) $0.796
(0.64%) $91.71
1.46% $ 218.15
Live Chart Being Loaded With Signals
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service...
Stats | |
---|---|
Tagesvolumen | 977 730 |
Durchschnittsvolumen | 1.11M |
Marktkapitalisierung | 32.05B |
EPS | $0 ( 2024-04-25 ) |
Nächstes Ertragsdatum | ( $1.990 ) 2024-08-01 |
Last Dividend | $0.480 ( 2023-11-08 ) |
Next Dividend | $0 ( N/A ) |
P/E | 33.61 |
ATR14 | $0.165 (0.08%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-29 | Burt Carol | Sell | 234 | ResMed Common Stock |
2024-04-29 | Drexler Karen | Sell | 425 | ResMed Common Stock |
2024-03-04 | Rider Michael J | Sell | 81 | ResMed Common Stock |
2024-03-01 | Rider Michael J | Sell | 200 | ResMed Common Stock |
2023-05-03 | Farrell Peter C | Sell | 12 600 | ResMed Common Stock |
INSIDER POWER |
---|
14.27 |
Last 97 transactions |
Buy: 212 786 | Sell: 179 948 |
Volumen Korrelation
Resmed Inc Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Resmed Inc Korrelation - Währung/Rohstoff
Resmed Inc Finanzdaten
Annual | 2023 |
Umsatz: | $4.22B |
Bruttogewinn: | $2.36B (55.78 %) |
EPS: | $6.12 |
FY | 2023 |
Umsatz: | $4.22B |
Bruttogewinn: | $2.36B (55.78 %) |
EPS: | $6.12 |
FY | 2022 |
Umsatz: | $3.58B |
Bruttogewinn: | $2.02B (56.57 %) |
EPS: | $5.34 |
FY | 2021 |
Umsatz: | $3.20B |
Bruttogewinn: | $1.84B (57.53 %) |
EPS: | $3.27 |
Financial Reports:
No articles found.
Resmed Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.440 (N/A) |
$0.440 (N/A) |
$0.440 (N/A) |
$0.440 (N/A) |
$0.480 (N/A) |
$0.480 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.170 | 2012-09-05 |
Last Dividend | $0.480 | 2023-11-08 |
Next Dividend | $0 | N/A |
Payout Date | 2023-12-14 | |
Next Payout Date | N/A | |
# dividends | 46 | -- |
Total Paid Out | $15.72 | -- |
Avg. Dividend % Per Year | 0.54% | -- |
Score | 4.86 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 7.25 | |
Div. Directional Score | 8.96 | -- |
Year | Amount | Yield |
---|---|---|
2012 | $0.340 | 1.33% |
2013 | $0.840 | 1.98% |
2014 | $1.060 | 2.29% |
2015 | $1.160 | 2.03% |
2016 | $1.260 | 2.41% |
2017 | $1.360 | 2.20% |
2018 | $1.440 | 1.68% |
2019 | $1.520 | 1.36% |
2020 | $1.560 | 1.00% |
2021 | $1.620 | 0.76% |
2022 | $1.720 | 0.66% |
2023 | $1.840 | 0.88% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend Knight | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
VGI | Dividend Royal | 2024-02-09 | Monthly | 13 | 7.36% | 8.50 |
KIO | Dividend Royal | 2023-12-14 | Monthly | 12 | 7.05% | 8.50 |
GOF | Dividend Royal | 2023-11-14 | Monthly | 18 | 8.03% | 8.50 |
PHK | Dividend Royal | 2023-11-10 | Monthly | 22 | 6.88% | 8.50 |
PCF | Dividend King | 2023-12-18 | Monthly | 38 | 7.05% | 8.50 |
ZTR | Dividend King | 2024-02-09 | Monthly | 37 | 8.35% | 8.50 |
PVL | Dividend King | 2023-11-15 | Monthly | 14 | 9.37% | 8.50 |
JQC | Dividend Royal | 2023-11-14 | Monthly | 22 | 6.56% | 8.50 |
NCV | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.68% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.216 | 1.500 | 5.69 | 8.53 | [0 - 0.5] |
returnOnAssetsTTM | 0.141 | 1.200 | 5.31 | 6.37 | [0 - 0.3] |
returnOnEquityTTM | 0.219 | 1.500 | 8.68 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.288 | -1.000 | 7.12 | -7.12 | [0 - 1] |
currentRatioTTM | 3.04 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 1.393 | 0.800 | 6.51 | 5.21 | [0.8 - 2.5] |
cashRatioTTM | 0.308 | 1.500 | 9.40 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.151 | -1.500 | 7.48 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -22.18 | 1.000 | -9.33 | -9.33 | [3 - 30] |
operatingCashFlowPerShareTTM | 8.16 | 2.00 | 7.28 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 7.29 | 2.00 | 6.36 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.223 | -1.500 | 9.11 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.573 | 1.000 | 3.79 | 3.79 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.273 | 1.000 | 6.54 | 6.54 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 1.162 | 1.000 | 4.65 | 4.65 | [0.2 - 2] |
assetTurnoverTTM | 0.652 | 0.800 | 8.98 | 7.19 | [0.5 - 2] |
Total Score | 10.68 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 33.45 | 1.000 | 6.72 | 0 | [1 - 100] |
returnOnEquityTTM | 0.219 | 2.50 | 9.15 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 7.29 | 2.00 | 7.57 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.862 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 8.16 | 2.00 | 7.28 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.288 | 1.500 | 7.12 | -7.12 | [0 - 1] |
pegRatioTTM | 11.66 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.270 | 1.000 | 5.76 | 0 | [0.1 - 0.5] |
Total Score | 7.25 |
Resmed Inc
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.